Question 1

What specific symptoms of Raynaud's phenomenon should I be experiencing to qualify for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon clinical trial (NCT00266669). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this gel compare to my current treatment options in terms of effectiveness and side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon clinical trial (NCT00266669). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of using the nitroglycerin gel?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon clinical trial (NCT00266669). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to apply the gel, and how long would the treatment last?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon clinical trial (NCT00266669). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of monitoring or follow-up would be required during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon clinical trial (NCT00266669). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks associated with stopping my current Raynaud's treatments for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon clinical trial (NCT00266669). Contact the study team or your healthcare provider for specific answers.

What this study is about